Back to announcement
20240531_INAF_Tanggapan atas Permintaan Penjelasan Bursa_31644879.pdf
Other Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 0943/DIR/V/2024
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 1
Perihal Penjelasan atas Pemberitaan Media Massa
Pemberitaan Media Massa
Merujuk permintaan penjelasan oleh Bursa Efek Indonesia melalui surat nomor S-04382/BEI.PP3/05-2024 tanggal 08
Mei 2024 perihal Permintaan Penjelasan Atas Pemberitaan di media massa terkait dengan pemberitaan:
Nama Media Judul Berita Tanggal
CNNIndonesia.com Kasus Dugaan Fraud Indofarma Bakal 08 May 2024
Dilaporkan ke Kejagung
Detik.com Siap-siap, Kasus Indofarma Bakal 07 May 2024
Dilaporkan ke Kejaksaan Agung!
Kami sampaikan penjelasan sebagai berikut:
No Pertanyaan
1. Klarifikasi atas kebenaran berita tersebut.
Terlampir
2. Informasi/kejadian penting lainnya yang material dan dapat mempengaruhi kelangsungan hidup
perusahaan serta dapat mempengaruhi harga saham perusahaan.
Terlampir
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Nama Pengirim Warjoko Sumedi
Jabatan Corporate Secretary
Tanggal dan Waktu 31-05-2024 15:38
Page 2
Lampiran 1. S 0943 ke BEI Tanggapan S-04382.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 0943/DIR/V/2024
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attachment 1
Subject Explanation for Mass Media
Recent Media Coverage
Referring to an explanation request by the Indonesia Stock Exchange through letter number S-04382/BEI.PP3/05-
2024 dated 08 Mei 2024 concerning Request for Explanation on Media Coverage related to:
Name of Media News Headline Date
CNNIndonesia.com Kasus Dugaan Fraud Indofarma Bakal 08 May 2024
Dilaporkan ke Kejagung
Detik.com Siap-siap, Kasus Indofarma Bakal 07 May 2024
Dilaporkan ke Kejaksaan Agung!
We submit the explanation as follows :
No Inquiries
1. Clarification of the truth of the news.
Terlampir
2. Other important material information / events that can affect going concern of the company and the
company's stock price.
Terlampir
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Sender Name Warjoko Sumedi
Function Corporate Secretary
Date and Time 31-05-2024 15:38
Page 4
Attachment 1. S 0943 ke BEI Tanggapan S-04382.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 5 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Indonesia Stock Exchange
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.